0.00Open0.00Pre Close0 Volume0 Open Interest15.00Strike Price0.00Turnover212.13%IV-94.30%PremiumNov 15, 2024Expiry Date7.28Intrinsic Value100Multiplier9DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9686Delta0.0310Gamma1.06Leverage Ratio-0.0081Theta-0.0020Rho-1.02Eff Leverage0.0009Vega
SIGA Technologies Stock Discussion
SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies
SIGA Technologies (NASDAQ: SIGA) has entered into an exclusive license agreement with Vanderbilt University for a portfolio of preclinical fully human monoclonal antibodies (mAbs). These mAbs have potential as treatments for a broad range of orthopoxviruses, including smallpox and mpox. The agreement grants SIGA exclusive rights to develop, manufacture...
SIGA Technologies Inc - Contract in Response to Morocco Ministry of Health Request. Makes first commercial sale in Africa
SIGA Announces Agreement to Supply TPOXX® in Morocco
wow, finally increasing a little... wondering if it's best to wait for before earnings report to buy in
https://www.msn.com/en-us/health/other/la-county-mpox-cases-are-rising-what-s-driving-the-increase/ar-AA1rbgw4?ocid=msedgdhp&pc=U531&cvid=3d9cefae83aa481fa5b56d8a24ecd771&ei=18
No comment yet